Roche Holding Company Profile (VTX:ROG)

About Roche Holding

Roche Holding logoRoche Holding AG is a research-based healthcare company. The Company develops, manufactures and delivers medicines, and diagnostic instruments and tests. Its operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. Its Pharmaceuticals division consists of two business segments: Roche Pharmaceuticals and Chugai. Its Diagnostics division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. It develops medicines for the disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its product portfolio consists of Pharmaceuticals, Solutions for Diagnostics and Products for Researchers. Its Pharmaceutical products include ACTEMRA and CellCept. Its Solutions for Diagnostics products include Accu-Chek Active System and Accu-Chek Aviva Nano System. The Company's Products for Researchers include Cedex HiRes and Genome Sequencer FLX System.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: VTX
  • Symbol: ROG
  • CUSIP:
Key Metrics:
  • Previous Close: $56.68
  • 50 Day Moving Average: $62.54
  • 200 Day Moving Average: $59.89
  • Trailing P/E Ratio: 26.11
  • P/E Growth: 1.27
  • Market Cap: $1.01B
Additional Links:
Companies Related to Roche Holding:

Analyst Ratings

Consensus Ratings for Roche Holding (VTX:ROG) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for Roche Holding (VTX:ROG)
Show:
DateFirmActionRatingPrice TargetDetails
8/8/2016JPMorgan Chase & Co.Reiterated RatingBuyView Rating Details
7/27/2016Citigroup Inc.Reiterated RatingBuyView Rating Details
7/19/2016Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details
11/13/2015Morgan StanleyReiterated RatingBuyView Rating Details
(Data available from 8/28/2014 forward)

Earnings

Earnings History for Roche Holding (VTX:ROG)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Roche Holding (VTX:ROG)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Roche Holding (VTX:ROG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Roche Holding (VTX:ROG)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Roche Holding (VTX:ROG)
DateHeadline
capitalcube.com logoETF’s with exposure to Rogers Corp. : August 24, 2016 (VTX:ROG)
www.capitalcube.com - August 24 at 6:53 PM
News IconPfizer Inc.: Medivation Acquisition Could Send Pfizer Stock Soaring - Profit Confidential (VTX:ROG)
www.profitconfidential.com - August 23 at 11:41 AM
finance.yahoo.com logoROGERS CORP Financials (VTX:ROG)
finance.yahoo.com - August 17 at 7:31 PM
capitalcube.com logoRogers Corp. :ROG-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (VTX:ROG)
www.capitalcube.com - August 12 at 7:17 PM
capitalcube.com logoETF’s with exposure to Rogers Corp. : August 11, 2016 (VTX:ROG)
www.capitalcube.com - August 11 at 7:41 PM
News IconSamsung Biologics likely to seek IPO approval (VTX:ROG)
www.legalbusinessonline.com - August 10 at 7:40 PM
thestreet.com logoNot-So-Jolly Rogers Thanks to Quant Downgrade, Bearish Chart (VTX:ROG)
realmoney.thestreet.com - August 10 at 7:40 PM
marketwatch.com logoSamsung BioLogics seeks to raise up to $2.5 billion from IPO - MarketWatch (VTX:ROG)
www.marketwatch.com - August 10 at 10:18 AM
reuters.com logoSamsung Biologics likely to seek IPO approval this week-bourse officials (VTX:ROG)
www.reuters.com - August 9 at 10:24 AM
sg.finance.yahoo.com logoRogers Corp. posts 2Q profit (VTX:ROG)
sg.finance.yahoo.com - August 8 at 7:25 PM
bizjournals.com logoBREAKING: New global corporate headquarters headed to Phoenix area (VTX:ROG)
www.bizjournals.com - August 8 at 7:25 PM
reuters.com logoSamsung Biologics likely to seek IPO approval this week-bourse officials - Reuters (VTX:ROG)
www.reuters.com - August 8 at 11:56 AM
biz.yahoo.com logoQ2 2016 Rogers Corp Earnings Release - After Market Close (VTX:ROG)
biz.yahoo.com - August 8 at 11:56 AM
reuters.com logoRegeneron sticks by 2016 growth forecast for Eylea, shares fall - Reuters (VTX:ROG)
www.reuters.com - August 5 at 7:23 PM
publicnow.com logoRogers Corporation Invites You to Join its 2016 Second Quarter Earnings Conference Call (VTX:ROG)
www.publicnow.com - August 1 at 10:51 AM
News IconPfizer Inc. (NYSE:PFE) Wins A $40 Million Bid By BIND Therapeutics Inc (NASDAQ:BIND) - WallStreetPR (blog) (VTX:ROG)
wallstreetpr.com - July 29 at 7:20 PM
reuters.com logoDiagnostics company LabCorp to buy smaller rival Sequenom - Reuters (VTX:ROG)
www.reuters.com - July 27 at 10:14 AM
investing.com logoEuropean stocks open mixed ahead of ECB policy decision; DAX up 0.22% - Investing.com (VTX:ROG)
www.investing.com - July 21 at 7:29 PM
finance.yahoo.com logoCrucial UK builds effective regulatory system: Roche CEO (VTX:ROG)
finance.yahoo.com - July 21 at 4:01 AM
finance.yahoo.com logoVery pleased with results: Roche CEO (VTX:ROG)
finance.yahoo.com - July 21 at 1:49 AM
News IconEuropean shares gain ground, but Turkish stocks fall after coup attempt - Morningstar.com (VTX:ROG)
www.morningstar.com - July 19 at 8:09 AM
4-traders.com logoRoche : 1st Half 2016 -- Forecast (VTX:ROG)
www.4-traders.com - July 18 at 12:41 PM
investing.com logoShire's (SHPG) Dry Eye Disease Drug Xiidra Gets FDA Nod - Investing.com (VTX:ROG)
www.investing.com - July 13 at 10:04 AM
investing.com logoSucampo To Stop Developing Cobiprostone For Oral Mucositis - Investing.com (VTX:ROG)
www.investing.com - July 13 at 10:04 AM
capitalcube.com logoRogers Corp. breached its 50 day moving average in a Bullish Manner : ROG-US : July 12, 2016 (VTX:ROG)
www.capitalcube.com - July 12 at 8:41 AM
reuters.com logoChina healthcare costs forcing patients into crippling debt - Reuters (VTX:ROG)
www.reuters.com - July 10 at 6:26 PM
News IconBristol-Myers Expands Cancer Research Pipeline, Purchases Cormorant - Mergers & Acquisitions - The Middle Market (VTX:ROG)
www.themiddlemarket.com - July 6 at 11:49 AM
publicnow.com logoRogers Corporation to Participate in CJS Securities, Inc. Sixteenth Annual “New Ideas” Summer Conference (VTX:ROG)
www.publicnow.com - July 5 at 11:11 AM
4-traders.com logoRoche : marketing applications for review of Ocrevus (ocrelizumab) in two forms of multiple sclerosis accepted by EMA and FDA (VTX:ROG)
www.4-traders.com - June 29 at 7:04 PM
capitalcube.com logoRogers Corp. – Value Analysis (NYSE:ROG) : June 21, 2016 (VTX:ROG)
www.capitalcube.com - June 21 at 11:35 AM
4-traders.com logoRoche : Phase III study shows Roche’s Actemra/RoActemra maintained steroid-free remission in people with Giant Cell Arteritis (GCA) (VTX:ROG)
www.4-traders.com - June 7 at 9:56 AM
feeds.reuters.com logoRPT-Study finds targeted cancer drugs may work in range of tumor types (VTX:ROG)
feeds.reuters.com - June 6 at 8:13 AM
4-traders.com logoRoche : First PT/INR home self-testing device with Bluetooth technology enabling remote care programmes for anticoagulated patients (VTX:ROG)
www.4-traders.com - May 31 at 8:06 AM
feeds.reuters.com logoU.S. FDA approves Roche's immunotherapy for bladder cancer (VTX:ROG)
feeds.reuters.com - May 18 at 2:04 PM
publicnow.com logoRogers Corporation to Participate in the B. Riley & Co.'s 17th Annual Investor Conference (VTX:ROG)
www.publicnow.com - May 18 at 9:52 AM
News IconRoche Holding Ltd. (VTX:ROG)'s Company Shares Decreased 1.86% After High Volatility - Franklin Independent (VTX:ROG)
www.franklinindependent.com - February 23 at 2:53 PM
reuters.com logoRoche eyes acquisition of Pacific Biosciences: sources - Reuters (VTX:ROG)
www.reuters.com - February 3 at 12:15 PM
reuters.com logoBristol-Myers set to lead earnings parade in 2016, beyond - Reuters (VTX:ROG)
www.reuters.com - January 30 at 6:53 PM
nasdaq.com logoEUROPE MARKETS: European Stocks Finish Lower; Germany Hurt By Euro Strength - Nasdaq (VTX:ROG)
www.nasdaq.com - January 28 at 7:09 PM
News IconEuropean stocks fall as earnings, Fed weigh - Morningstar.com (VTX:ROG)
news.morningstar.com - January 28 at 7:09 PM
reuters.com logoBristol-Myers set to lead earnings parade in 2016, beyond - Reuters UK (VTX:ROG)
uk.reuters.com - January 28 at 7:09 PM
nasdaq.com logoEUROPE MARKETS: European Stocks Knocked Down, With Germany Hurt By Euro Strength - Nasdaq (VTX:ROG)
www.nasdaq.com - January 28 at 11:59 AM
nasdaq.com logoRoche FY15 Net Profit Down, But Sales Up; Sees Growth In FY16 (VTX:ROG)
www.nasdaq.com - January 28 at 2:20 AM
gurufocus.com logoInvesco European Growth Fund Adds to 7 Stakes - GuruFocus.com (VTX:ROG)
www.gurufocus.com - January 27 at 6:54 PM
News IconCompany Shares of Rogers Corporation (NYSE:ROG) Rally 3.09% - The Daily Rover (VTX:ROG)
thedailyrover.com - January 25 at 11:34 AM
News IconShares of Rogers Corporation (NYSE:ROG) Sees Large Outflow of Money - The Daily Rover (VTX:ROG)
thedailyrover.com - January 22 at 6:32 PM
insidermonkey.com logoTop Investors Losing Faith In Rogers Corporation (ROG) (VTX:ROG)
www.insidermonkey.com - November 28 at 6:59 PM

Social


Last Updated on 8/28/2016 by MarketBeat.com Staff